Med. praxi. 2022;19(3):215-219 | DOI: 10.36290/med.2022.035
Insulin therapy is an integral part of the treatment of type 2 diabetes for 100 years. Recent developments of insulins with different kinetics, the evolution of insulin pumps, and the integration of continuous glucose monitoring led to new possibilities and standards of care. This paper focuses on current standards of clinical care with regard to the availability/limitations of these instruments by health insurance providers in the Czech Republic and the implications of these technologies in the treatment of different types of diabetes.
Published: June 16, 2022 Show citation